Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-06 Sale |
2025-03-10 12:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer |
1,785 | $40.4 | $72,114 | 106,169 (Direct) |
View |
| 2024-10-10 Sale |
2024-10-11 4:48 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer |
7,465 | $52.76 | $393,853 | 92,301 (Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:36 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
2,248 | $25.97 | $58,387 | 230,712 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-21 7:22 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
2,424 | $25.29 | $61,298 | 232,960 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 5:00 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
2,393 | $31.93 | $76,411 | 200,384 (Direct) |
View |
| 2020-07-13 Sale |
2020-07-15 4:50 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
30,000 | $50.06 | $1,501,731 | 177,777 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 6:42 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
20,000 | $38.92 | $778,399 | 207,777 (Direct) |
View |
| 2020-06-25 Sale |
2020-06-26 5:00 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
30,000 | $50 | $1,500,000 | 227,777 (Direct) |
View |
| 2020-06-19 Sale |
2020-06-23 5:00 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
10,000 | $40 | $400,000 | 257,777 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-02 9:14 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
10,000 | $35.1 | $351,038 | 267,777 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 7:56 pm |
N/A 2035-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer |
43,813 | $0 | 136,114 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:23 pm |
N/A 2034-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer |
53,600 | $0 | 133,966 (Direct) |
View |
| 2023-10-09 Option Award |
2023-10-10 12:50 pm |
N/A 2033-10-09 |
Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer |
220,835 | $0 | 220,805 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:29 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
85,000 | $0 | 285,384 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 5:01 pm |
N/A 2031-02-15 |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
75,000 | $0 | 252,777 (Direct) |
View |